Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
CTOR
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w low +71.0%
CTOR
Citius Oncology, Inc. Common Stock
☁️ News word cloud
Top words across the last 50 articles for this ticker.
citius
oncology
million
launch
lymphir
offering
2025
placement
announces
reported
registered
direct
private
commercial
cancer
revenue
cutaneous
cell
lymphoma
concurrent
StonvexStonvexStonvexStonvex